Breathe Well Live Well
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire (press release) The data, presented at the 2016 Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) in Vienna, confirm that GRAZAX® can prevent asthma symptoms, as well as offering sustained relief from grass allergy symptoms. |
View full post on asthma – Google News
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire UK (press release) ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today presented new data from the GRAZAX® Asthma Prevention (GAP) trial with GRAZAX®, ALK's allergy immunotherapy tablet against grass pollen allergy. The data, presented at the 2016 Annual Congress … |
View full post on asthma – Google News
FiercePharma |
PhIII data puts AZ one step closer to severe-asthma showdown with GSK
FiercePharma Last week, the British drugmaker announced that its candidate for severe asthma with eosinophilic inflammation–benralizumab–had nailed its primary endpoint in two Phase III studies, beating out placebo at paring down the annual asthma exacerbation … |
View full post on asthma – Google News
 |
Related Articles |
Medical care and treatment of allergic rhinitis. A population-based cohort study based on routine healthcare utilization data.
Allergy. 2016 Jan 8;
Authors: Schmitt J, Stadler E, Küster D, Wüstenberg EG
Abstract
BACKGROUND: Health services research on medical care and treatment of allergic rhinitis (AR) is scarce.
OBJECTIVES: To investigate the prevalence, incidence, comorbidities, and treatment of AR in a realistic setting.
METHODS: A cohort of 1,811,094 German National Health Insurance beneficiaries in 2005 was followed until 2011. To avoid misclassification, the ICD-10-code for AR (J30) had to be documented at least twice to classify patients as having AR. Descriptive statistics and logistic regression models were used to describe the burden, comorbidities, and treatment of AR.
RESULTS: A total of 111,394 patients (6.2%) had prevalent AR in 2005/2006. In another 60,145 individuals (3.3%) AR was newly diagnosed in 2007 to 2011 (incident cases). Patients with prevalent AR were three times more likely to develop asthma compared to patients without AR (age and sex-adjusted risk ratio (RR) 3.04; 95% confidence interval (95%CI) 2.98 – 3.10). Newly diagnosed recurrent depressive disorder (RR 1.61; 95%CI 1.55 – 1.68), anxiety disorder (RR 1.52; 95%CI 1.48 – 1.56) and ADHD (RR 1.21; 95%CI 1.13 – 1.29) were also related to prevalent AR. Approximately 20% of children and 36% of adults with AR were exclusively treated by general practitioners. Allergy immunotherapy (AIT) was prescribed for 16.4% of AR patients. Subcutaneous immunotherapy was most frequently used (80% of AIT).
CONCLUSIONS: This study highlights the significant burden of AR. Despite the established benefits of AIT to treat AR and prevent asthma this study suggests significant undertreatment. Future research is necessary to develop and implement adequate measures to increase guideline adherence. This article is protected by copyright. All rights reserved.
PMID: 26749452 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
|
App for Kids to ID Asthma Attack Triggers
Health Data Management A UCLA-USC team under a $6 million grant from the National Institute of Biomedical Imaging and Bioengineering will develop kid-friendly technology enabling smartphones and smart watches to identify risk factors and environmental triggers for asthma … |
View full post on asthma – Google News
|
Asthma App Improves Patient Health, Eases Doc Jobs
Health Data Management A mobile phone app for asthma patients appears to help them improve their health, according to preliminary results of a study evaluating use of the app. Other dividends of the app include making it easier for clinicians glean useful data, and the study … |
View full post on asthma – Google News
|
Positive Data Presented on Pieris Pharmaceuticals' Inhaled Asthma Program at …
Benzinga Prior to joining Pieris Dr. Fitzgerald held senior positions at Argenta Discovery and Pulmagen Therapeutics, where she was responsible for clinical development of inhaled and oral drug candidates for both COPD and asthma. Previously, she was employed … |
View full post on asthma – Google News
Pakistan Christian Post |
Wake up call on asthma in children: New data must drive well-coordinated action!
OpEdNews If we listen to asthma experts and look at evidence, one reality becomes starkly clear: we have neglected asthma in children for far too long! "I think we have 'gone to sleep a bit' on asthma in resource-limited settings. The International Union … PCP Menu Toggle navigation |
View full post on asthma – Google News
|
Wake up call on asthma in children: New data must drive well-coordinated action!
TheHealthSite If we listen to asthma experts and look at evidence, one reality becomes starkly clear: we have neglected asthma in children for far too long! 'I think we have 'gone to sleep a bit' on asthma in resource-limited settings. The International Union … |
View full post on asthma – Google News
|
Researchers using iPhones to collect data on Parkinson's, asthma, other ills …
Newser In this July 2, 2015 photo, asthma sufferer Elizabeth Ortiz, who uses the Asthma Health smartphone app daily to track her condition, poses for photos at her apartment, on New York's Lower East Side. Ortiz… (Associated Press) … |
View full post on asthma – Google News